Masucci C, Franchi L, Giuntini V, Defraia E
Department of Surgery and Translational Medicine, The University of Florence, Florence, Italy.
Orthod Craniofac Res. 2014 Nov;17(4):259-69. doi: 10.1111/ocr.12051. Epub 2014 Jul 7.
To assess the effects of a modified alternate rapid maxillary expansion and constriction (Alt-RAMEC) protocol in combination with facemask (FM) in Class III growing patients.
Thirty one Class III patients (17 males, 14 females) were treated with a modified Alt-RAMEC/FM protocol at the Department of Orthodontics of the University of Florence.
All patients were evaluated at the beginning (T1, mean age 6.4 ± 0.8 years) and at the end of orthopedic therapy (T2, mean age 8.1 ± 0.9 years), and they were compared to a matched sample of 31 Class III patients (16 males and 15 females) treated with rapid maxillary expansion and facemask (RME/FM) and to a matched control group of 21 subjects (9 males and 12 females) with untreated Class III malocclusion. The three groups were compared with anova with Benjamini-Hochberg correction for multiple tests.
Both the Alt-RAMEC/FM and the RME/FM protocols showed significantly favorable effects leading to correction of the Class III malocclusion. The Alt-RAMEC/FM protocol produced a more effective advancement of the maxilla (SNA +1.2°) and greater intermaxillary changes (ANB +1.7°) vs. the RME/FM protocol. No significant differences were recorded as for mandibular skeletal changes and vertical skeletal relationships.
The Alt-RAMEC/FM protocol induced more favorable skeletal short-term effects compared with RME/FM therapy in Class III growing patients.
评估改良交替式快速上颌扩弓与缩弓(Alt-RAMEC)方案联合面罩(FM)对Ⅲ类生长发育期患者的影响。
31例Ⅲ类患者(17例男性,14例女性)在佛罗伦萨大学正畸科接受改良Alt-RAMEC/FM方案治疗。
所有患者在开始时(T1,平均年龄6.4±0.8岁)和正畸治疗结束时(T2,平均年龄8.1±0.9岁)接受评估,并与31例接受快速上颌扩弓与面罩(RME/FM)治疗的匹配Ⅲ类患者样本以及21例未经治疗的Ⅲ类错牙合畸形患者的匹配对照组(9例男性和12例女性)进行比较。三组通过方差分析及Benjamini-Hochberg多重检验校正进行比较。
Alt-RAMEC/FM和RME/FM方案均显示出显著的有利效果,导致Ⅲ类错牙合畸形得到矫正。与RME/FM方案相比,Alt-RAMEC/FM方案使上颌骨有更有效的前移(SNA增加1.2°)和更大的颌间变化(ANB增加1.7°)。在下颌骨骨骼变化和垂直骨骼关系方面未记录到显著差异。
与RME/FM治疗相比,Alt-RAMEC/FM方案在Ⅲ类生长发育期患者中诱导出更有利的短期骨骼效果。